Pulse Biosciences, Inc.
PLSE· Nasdaq
Filed Nov 1, 2018 · 10-Q · 32 days after period end · 0001625101-18-000052
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Net Income | -$10.76M | -$7.49M | -$2.77M | -$751.00K |
| EPS Diluted | -$0.64 | -$0.52 | -$0.21 | -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pulse Biosciences, Inc. · CIK 1625101 · Engraved from SEC EDGAR
ended Sep 30, 2018 · filed Nov 1, 2018 · 32 d after period end